Published in Gene Therapy Weekly, July 13th, 2000
"Tumor necrosis factor alpha (TNF alpha) increases the survival and proliferation of human rheumatoid arthritis (RA) cell lines," stated H.G. Zhang and colleagues from the University of Alabama. "These experiments were designed to determine if inhibition of nuclear factor KB (NF-KB) nuclear translocation leads to increased apoptosis of TNF alpha-treated human RA cell lines.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.